HealthifyMe merges with Berry Street, eyes India pharma, insurer and offline growth

HealthifyMe has completed an all-stock merger with New York-based Berry Street, placing its India business under a US parent. The nutrition platform plans to deepen India partnerships with pharma and insurers, including Novo Nordisk, while assessing a physical-centre-to-digital expansion model.

— Source publishedMon, 24 Aug, 2026, 19:32 IST·First seen Mon, 24 Aug, 2026, 19:39 IST·Source Mint

What happened

HealthifyMe merged with New York-based Berry Street in an all-stock deal, making its India business a subsidiary. It will deepen India operations through pharma

Key facts

  • 18 months
  • $95 billion global weight-loss drug market by 2030
  • Almost half of HealthifyMe's engineering team reallocated to US and international markets
  • US public offering potentially at least 24 months away
  • India weight-management market estimated at $27.4 billion in 2025 and projected at $56.7 billion by 2034

Why this matters

The deal illustrates how cross-border mergers can combine digital care platforms and open strategic channels in pharma, insurance and offline health services, making adjacent partnership targets more attractive.

What to watch

  • Named commercial launch, patient-support agreement or expanded partnership with Novo Nordisk or another metabolic-care pharmaceutical company.
  • Insurer reimbursement, cashless-benefit inclusion or a large employer contract in India.
  • Announcement of physical centres, clinic partnerships, pharmacy-counter programs or diagnostic-lab integrations.
  • Evidence that the merged entity is selling a common enterprise product across India and the US.
  • Metrics on paid-member retention, clinician capacity, conversion from offline consultations to digital plans and customer-acquisition costs.
  • Regulatory or privacy developments affecting cross-border health-data governance and telehealth operations.
  • Formalize India commercial programs with pharma companies focused on obesity, diabetes and cardiovascular-risk management, including patient-support pathways around prescription therapies.
  • Pursue insurer and employer contracts that bundle nutrition coaching with preventive-care, diagnostics and chronic-condition benefits.
  • Pilot a small number of physical care centres or co-located clinics in major Indian metros, using them as lead-generation and trust-building hubs for digital care.
  • Integrate Berry Street's clinician network, protocols and enterprise-sales capabilities into a unified cross-border offering.
  • Develop pharmacy, diagnostic-lab and hospital partnerships to create referral, testing and medication-adherence loops.

Also reported by